Pregled bibliografske jedinice broj: 1159341
Echolucency-based phenotype in carotid atherosclerosis disease for risk stratification of diabetes patients
Echolucency-based phenotype in carotid atherosclerosis disease for risk stratification of diabetes patients // Diabetes Research and Clinical Practice, 143 (2018), 322-331 doi:10.1016/j.diabres.2018.07.028 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1159341 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Echolucency-based phenotype in carotid
atherosclerosis disease for risk stratification of
diabetes patients
Autori
Kotsis, Vasileios ; Jamthikar, Ankush D. ; Araki, Tadashi ; Gupta, Deep ; Laird, John R. ; Giannopoulos, Argiris A. ; Saba, Luca ; Suri, Harman S. ; Mavrogeni, Sophie ; Kitas, George D. ; Višković, Klaudija ; Khanna, Narendra N. ; Gupta, Ajay ; Nicolaides, Andrew ; Suri, Jasjit S.
Izvornik
Diabetes Research and Clinical Practice (0168-8227) 143
(2018);
322-331
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Age-adjusted grayscale median ; Carotid atherosclerosis ; Diabetes ; Hemoglobin ; Plaque echolucency ; Ultrasound
Sažetak
Aim: The study investigated the association of carotid ultrasound echolucent plaque-based biomarker with HbA1c, measured as age-adjusted grayscale median (AAGSM) as a function of chronological age, total plaque area, and conventional grayscale median (GSMconv). Methods: Two stages were developed: (a) automated measurement of carotid parameters such as total plaque area (TPA) ; (b) computing the AAGSM as a function of GSMconv, age, and TPA. Intra-operator (novice and experienced) analysis was conducted. Results: IRB approved, 204 patients' left/right CCA (408 images) ultrasound scans were collected: mean age: 69 ± 11 years ; mean HbA1c: 6.12 ± 1.47%. A moderate inverse correlation was observed between AAGSM and HbA1c (CC of -0.13, P = 0.01), compared to GSM (CC of -0.06, P = 0.24). The RCCA and LCCA showed CC of -0.18, P < 0.01 and -0.08 ; P < 0.24. Female and males showed CC of -0.29, P < 0.01 and -0.10, P = 0.09. Using the threshold for AAGSM and HbA1c as: low-risk (AAGSM > 100 ; HbA1c < 5.7%), moderate-risk (40 < AAGSM < 100 ; 5.7% < HbA1c < 6.5%) and high-risk (AAGSM < 40 ; HbA1c > 6.5%), the area under the curve showed a better performance of AAGSM over GSMconv. A paired t-test between operators and expert (P < 0.0001) ; inter- operator CC of 0.85 (P < 0.0001). Conclusions: Echolucent plaque in patients with diabetes can be more accurately characterized for risk stratification using AAGSM compared to GSMconv.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za infektivne bolesti "Dr Fran Mihaljević",
Zdravstveno veleučilište, Zagreb,
Fakultet zdravstvenih studija u Rijeci
Profili:
Klaudija Višković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE